UK study digs into Hard-to-Treat virus after kidney transplants
NCT ID NCT06568055
First seen Jan 05, 2026 · Last updated May 13, 2026 · Updated 15 times
Summary
This study looked back at medical records of 330 kidney transplant patients in the UK to learn more about cytomegalovirus (CMV) infections that are hard to treat. The goal was to count how often these infections happen, what treatments are used, and how well they work. No new treatments were given—researchers simply analyzed existing data from a national kidney disease registry.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CYTOMEGALOVIRUS (CMV) are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
RaDaR (part of the UK Kidney Association)
Bristol, Southwestern England, United Kingdom
Conditions
Explore the condition pages connected to this study.